Cell biology of the osteoclast

Experimental Hematology

Volumn 27, Issue 8, 1999, Pages 1229-1241

  Roodman, G David ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Bone resorption; Osteoclast; Precursor

Indexed keywords

PROTEIN C FOS; PROTEIN KINASE P60;

BONE MARROW CELL; CELL DIFFERENTIATION; COLONY FORMING UNIT GM; HEMATOPOIETIC CELL; HUMAN; NONHUMAN; ONCOGENE C FOS; ONCOGENE SRC; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BONE MARROW; BONE RESORPTION; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; CELL SEPARATION; CHO CELLS; CRICETINAE; CYTOKINES; GLYCOPROTEINS; HORMONES; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; ORGAN CULTURE TECHNIQUES; OSTEOCLASTS; OSTEOPROTEGERIN; PROTO-ONCOGENES; RANK LIGAND; RATS; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; STROMAL CELLS; TRANSFECTION;

EID: 0032765892     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(99)00061-2     Document Type: Review

References (120)

1. Baron R., Neff L., Van P.T., Nefussi J.R., Vignery A. Kinetic and cytochemical identification of osteoclast precursors and their differentiation into multinucleated osteoclasts. Am J Pathol. 121:1986;363.
2. Burger E.H., Van der Meer J.W.M., van de Gevel J.S., Gribnau J.C., Thesingh C.W., van Furth R. In vitro formation of osteoclasts from long-term cultures of bone marrow mononuclear phagocytes. J Exp Med. 156:1982;1604.
3. Kurihara N., Chenu C., Civin Cl Roodman G.D. Identification of committed mononuclear precursors for osteoclast-like cells formed in long-term marrow cultures. Endocrinology. 126:1990;2733.
4. Matsuzaki K., Udagawa N., Takahashi N., Yamaguchi K., Yasuda H., Shima N., Morinaga T., Toyama Y., Yabe Y., Higashio K., Suda T. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. Biochem Biophys Res Comm. 246:1998;199.
5. Lee S.K., Goldring S.R., Lorenzo J.A. Expression of the calcitonin receptor in bone marrow cell cultures and in bone. a specific marker of the differentiated osteoclast that is regulated by calcitonin Endocrinology. 136:1995;4572.
6. Wada S., Martin T.J., Findlay D.M. Homologous regulation of the calcitonin receptor in mouse osteoclast-like cells and human breast cancer T47D cells. Endocrinology. 136:1995;2611.
7. Ikegame M., Rakopoulos M., Zhou H., Houssami S., Martin T.J., Moseley J.M., Findlay D.M. Calcitonin receptor isoforms in mouse and rat osteoclasts. J Bone Miner Res. 10:1995;59.
8. Kukita T., McManus L.M., Miller M., Civin C., Roodman G.D. Osteoclast-like cells formed in long-term human bone marrow cultures express a similar surface phenotype as authentic osteoclasts. Lab Invest. 60:1989;532.
9. Wesolowski G., Duong L.T., Lakkakorpi P.T., Nagy R.M., Tezuka K.I., Tanaka H., Rodan G.A., Rodan S.B. Isolation and characterization of highly enriched, prefusion mouse osteoclastic cells. Exp Cell Res. 219:1995;679.
10. Osdoby P., Martini M.C., Caplan Al lsolated osteoclasts and their presumed progenitor cells, the monocyte, in culture. J Exp Zool. 224:1982;331.
11. Zambonin-Zallone A., Tete A., Primavera M.V. Isolated osteoclasts in primary culture. first observations on structure and survival in cultured media Anat Embryol. 165:1982;405.
12. Tezuka K., Tezuka Y., Maejima A., Sato T., Nemoto K., Kamioka H., Hakeda Y., Kumegawa M. Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts. J Biol Chem. 269:1994;1106.
13. Uy H.L., Dallas M., Calland J.W., Boyce B.F., Mundy G.R., Roodman G.D. Use of an in vivo model to determine the effects of interleukin-1 on cells at different stages in the osteoclast lineage. J Bone Miner Res. 10:1995;295.
14. Testa N.G., Allen T.D., Lajtha L.G., Onions D., Jarrets O. Generation of osteoclasts in vitro. J Cell Sci. 44:1981;127.
15. lbbotson K.J., Roodman G.D., McManus L.M., Mundy G.R. ldentification and characterization of osteoclast-like cells and their progenitors in cultures of feline marrow mononuclear cells. J Cell Biol. 94:1984;471.
16. Takahashi N., Yamana H., Yoshiki S., Roodman G.D., Mundy G.R., Jones S.J., Boyde A., Suda T. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology. 122:1988;1373.
17. 3 causes formation of multinucleated cells with several osteoclast characteristics in cultures of primate marrow. Proc Natl Acad Sci U S A. 82:1985;8213.
18. MacDonald B.R., Takahashi N., McManus L.M., Holahan J., Mundy G.R., Roodman G.D. Formation of multinucleated cells that respond to osteotropic hormones in long-term human bone marrow cultures. Endocrinology. 120:1987;2326.
19. 3 induces differentiation of osteoclast-like cells from human bone marrow cultures. Biochem Biophys Res Commun. 176:1991;1189.
20. Kassem M., Mosekilde L., Rungby J., Mosekilde L., Melsen F., Eriksen E.F. Formation of osteoclasts and osteoblast-like cells in long-term human bone marrow cultures. APMIS. 99:1991;262.
21. Udagawa N., Takahashi N., Akatsu T., Sasaki T., Yamaguchi A., Kodama H., Martin T.J., Suda T. The bone marrow derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology. 125:1989;1805.
22. Akatsu T., Tamura T., Takahashi N., Udagawa N., Tanaka S., Sasaki T., Yamaguchi A., Nagata N., Suda T. Preparation and characterization of a mouse osteoclast-like multinucleated cell population. J Bone Miner Res. 7:1992;1297.
23. Tamura T., Takahashi N., Akatsu T., Sasaki T., Udagawa N., Tanaka S., Suda T. New resorption assay with mouse osteoclast-like multinucleated cells formed in vitro. J Bone Miner Res. 8:1993;953.
24. L and Simian Virus 40 large T antigen to the osteoclast lineage in transgenic mice. J Clin Invest. 102:1998;88.
25. Chen W., Li Y.P. Generation of mouse osteoclastogenic cell lines immortalized with SV40 large T antigen. J Bone Miner Res. 13:1998;1112.
26. Takahashi N., Akatsu T., Udagawa N., Sasaki T., Yamaguchi A., Moseley J.M., Martin T.J., Suda T. Osteoblastic cells are involved in osteoclast formation. Endocrinology. 123:1988;2600.
27. Matsumoto H.N., Tamura M., Denhardt D.T., Obinata M., Noda M. Establishment and characterization of bone marrow stromal cell lines that support osteoclastogenesis. Endocrinology. 136:1995;4084.
28. Kodama H., Nose M., Niida S., Yamasaki A. Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells. J Exp Med. 173:1991;1291.
29. Lacey D.L., Timms E., Tan H.L., Kelley M.J., Dunstan C.R., Burgess T., Elliott R., Colombero A., Elliott G., Scully S., Hsu H., Sullivan J.et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 93:1998;165.
30. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Mochizuki S., Tomoyasu A., Yano K., Goto M., Murakami A., Tsuda E., Morinaga T.et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A. 95:1998;3597.
31. Hofbauer L.C., Heufelder A.E. Osteoprotegerin and its cognate ligand. a new paradigm of osteoclastogenesis Eur J Endo. 139:1998;152.
32. Tsukii K., Shima N., Mochizuki S., Yamaguchi K., Kinosaki M., Yano K., Shibata O., Udagawa N., Yasuda H., Suda T., Higashio K. Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone. Biochem Biophys Res Comm. 246:1998;337.
33. Simonet W.S., Lacey D.L., Dunstan C.R., Kelley M., Chang M.S., Luthy R., Nguyen H.Q., Wooden S., Bennett L., Boone T., Shimomoto G., De Rose M. Osteoprotegerin. a novel secreted protein involved in the regulation of bone density Cell. 89:1997;309.
34. Yasuda H., Shima N., Nakagawa N., Mochizuki S., Yano K., Fujise N., Sato Y., Goto M., Yamaguchi K., Kuriyama M., Kanno T., Murakami A.et al. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG). a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro Endrocrinology. 139:1998;1329.
35. Mizuno A., Amizuka N., Irie K., Murakami A., Fujise N., Kanno T., Sato Y., Nakagawa N., Yasuda H., Mochizuki S., Gomibuchi T., Yano K.et al. Severe osteoporosis in mice lacking osteoblastogenesis inhibitory factor osteoprotegerin. Biochem Biophys Res Commun. 247:1998;610.
36. Gowen M., Meikle M.C., Reynolds J.J. Stimulation of bone resorption in vitro by a non-prostanoid factor released by human monocytes in culture. Biochem Biophys Acta. 762:1983;471.
37. Pfeilschifter J., Chenu C., Bird A., Mundy G.R., Roodman G.D. Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclast-like cells in vitro. J Bone Miner Res. 4:1989;113.
38. Fried R.M., Voelkel E.F., Rice R.H., Levine L., Gaffney E.V., Tashjian A.H. Two squamous cell carcinomas not associated with humoral hypercalcemia produce a potent bone resorption-stimulating factor which is interleukin-1 alpha. Endocrinology. 125:1989;742.
39. Sato K., Fujii Y., Kasono K., Ozawa M., Imamura H., Kanaji Y., Kurosawa H., Tsushima T., Shizume K. Parathyroid hormone-related protein and interleukin-1α synergistically stimulate bone resorption in vitro and increase the serum calcium concentration in mice in vivo. Endocrinology. 124:1989;2172.
40. Kawano M., Tanaka H., Ishikawa H., Nobuyoshi M., Iwato K., Asaoku H., Tanabe O., Kuramoto A. Interleukin-1 accelerates autocrine growth of myeloma cells through interleukin-6 in human myeloma. Blood. 73:1989;2145.
41. Cozzolino F., Torcia M., Aldinucci D., Rubartelli A., Miliani A., Shaw A.R., Lansdor P.M., Diguglielmo R. Production of interleukin-1 by bone marrow myeloma cells. Blood. 74:1989;380.
42. Yoshida H., Hayashi S., Kunisada T., Ogawa M., Nishikawa S., Okumura H., Sudo T., Schultz L.D., Nishikawa S. The murine mutation osteopetrosis is in the coding region of the macrophage colony-stimulating factor gene. Nature. 345:1990;442.
43. Sundquist K.T., Cecchini M.G., Marks S.C. Jr. Colony-stimulating factor-1 injections improve but do not cure skeletal sclerosis in osteopetrotic (op) mice. Bone. 16:1995;39.
44. Nilsson S.K., Lieschke G.J., Garcia-Wijnen C.C., Williams B., Tzelepis D., Hodgson G., Grail D., Dunn A.R., Bertoncello I. Granulocyte-macrophage colony-stimulating factor is not responsible for the correction of hematopoietic deficiencies in the maturing op/op mouse. Blood. 86:1995;66.
45. Weir E.C., Horowitz M.C., Baron R., Centrella M., Kacinski B.M., Insogna K.L. Macrophage colony-stimulating factor release and receptor expression in bone cells. J Bone Miner Res. 8:1993;1507.
46. Fuller K., Owens J.M., Jagger C.J., Wilson A., Moss R., Chambers T.J. Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J Exp Med. 178:1993;1733.
47. Yates A.J.P., Favarato G., Aufdemorte T.B., Marcelli C., Kester M.B., Walker R., Langton B.C., Bonewald L., Mundy G.R. Expression of human transforming growth factor α by Chinese hamster ovarian tumors in nude mice causes hypercalcemia and increased osteoclastic bone resorption. J Bone Miner Res. 7:1992;847.
48. Takahashi N., MacDonald B.R., Hon J., Winkler M.E., Derynck R., Mundy G.R., Roodman G.D. Recombinant human transforming growth factor-α stimulates the formation of osteoclast-like cells in long-term human marrow cultures. J Clin Invest. 78:1986;894.
49. Thomson B.M., Saklatvala J., Chambers T.J. Osteoblasts mediate interleukin-1 stimulation of bone resorption by rat osteoclasts. J Exp Med. 164:1986;104.
50. Thomson B.M., Mundy G.R., Chambers T.J. Tumor necrosis factors alpha and beta induce osteoclastic cells to stimulate osteoclastic bone resorption. J Immunol. 138:1987;775.
51. Garrett I.R., Durie B.G.M., Nedwin G.E. Production of the bone-resorbing cytokine lymphotoxin by cultured human myeloma cells. N Engl J Med. 317:1987;526.
52. Alsina M., Boyce B., Devlin R., Anderson J.L., Craig F., Mundy G.R., Roodman G.D. Development of an in vivo model of human multiple myeloma bone disease. Blood. 87:1996;1495.
53. Yoneda T., Alsina M.A., Chavez J.B., Bonewald L., Nishimura R., Mundy G.R. Evidence that tumor necrosis factor plays a pathogenetic role in the paraneoplastic syndromes of cachexia, hypercalcemia, and leukocytosis in a human tumor in nude mice. J Clin Invest. 87:1991;977.
54. Lowik C.W.G.M., van der Pluijm G., Bloys H., Hoekman K., Bijvoet O.L.M., Aarden L.A., Papapoulos S.E. Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells. a possible role of interleukin-6 in osteoclastogenesis Biochemic Biophys Res Commun. 162:1989;1546.
55. Kurihara N., Bertolini D., Suda T., Akiyama Y., Roodman G.D. IL-6 stimulates osteoclast-like multinucleated cell formation in long-term human marrow cultures by inducing IL-1 release. J Immunol. 144:1990;4226.
56. De La Mata J., Uy H.L., Guise T.A., Story B., Boyce B.F., Mundy G.F., Roodman G.D. IL-6 enhances hypercalcemia and bone resorption mediated by PTH-rP in vivo. J Clin Invest. 95:1995;2846.
57. Tamura T., Udagawa N., Takahashi N., Miyaura C., Tanaka S., Yamada Y., Koishihara Y., Ohshugi Y., Kumaki K., Taga T., Kishimoto T., Suda T. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin-6. Proc Natl Acad Sci U S A. 90:1993;11924.
58. Ohsaki Y., Takahashi S., Scarcez T., Demulder A., Nishihara T., Williams R., Roodman G.D. Evidence for an autocrine/paracrine role for IL-6 in bone resorption by giant cell tumors of bone. Endocrinology. 131:1992;2229.
59. Roodman G.D., Kurihara N., Ohsaki Y., Kukita A., Hosking D., Demulder A., Singer F.R. Interleukin-6. a potential autocrine/paracrine factor in Paget's disease of bone J Clin Invest. 89:1992;46.
60. Paul S.R., Bennett F., Calvetti J.A., Kelleher K., Wood C.R., O'Hara R.M., Leary A.C., Sibley B., Clark S.C., Williams D.A., Yang Y.C. Molecular cloning of a cDNA encoding interleukin-11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc Natl Acad Sci U S A. 87:1990;7512.
61. Girasole G., Passeri G., Jilka R.L., Manolagas S.C. Interleukin-11. a new cytokine critical for osteoclast development J Clin Invest. 93:1994;1516.
62. Mundy G.R. The effects of TGF-beta on bone. Ciba Foundation Suppl. 157:1991;137.
63. Dieudonne S.C., Foo P., van Zoelen E.J., Burger E.H. Inhibiting and stimulating effects of TGF-beta 1 on osteoclastic bone resorption in fetal mouse bone organ cultures. J Bone Miner Res. 6:1991;479.
64. Chenu C., Pfeilschifter J., Mundy G.R., Roodman G.D. Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures. Proc Natl Acad Sci U S A. 85:1988;5683.
65. Ikeda T., Shigeno C., Kasai R., Kohno H., Ohta S., Okumura H., Konishi J., Yamamuro T. Ovariectomy decreases the mRNA levels of transforming growth factor-beta 1 and increases the mRNA levels of osteocalcin in rat bone in vivo. Biochem Biophys Res Commun. 194:1993;1228.
66. Pfeilschifter J., Mundy G.R. Modulation of transforming growth factor β activity in bone cultures by osteotropic hormones. Proc Natl Acad Sci U S A. 84:1987;2024.
67. Gowen M., Mundy G.R. Actions of recombinant interleukin-1, interleukin-2, and interferon gamma on bone resorption in vitro. J Immunol. 136:1986;2478.
68. Takahashi N., Mundy G.R., Roodman G.D. Recombinant human gamma interferon inhibits formation of osteoclast like cells by inhibiting fusion of their precursors. J Immunol. 137:1986;3544.
69. Tohkin M., Kakudo S., Kasai H., Arita H. Comparative study of inhibitory effects by murine interferon gamma and a new bisphosphonate (alendronate) in hypercalcemic, nude mice bearing human tumor (LJC-1-JCK). Cancer Immunol Immunother. 39:1994;155.
70. Shioi A., Teitelbaum S.L., Ross F.P., Welgus H.G., Suzuki H., Ohara J., Lacey D.L. Interleukin-4 inhibits murine osteoclast formation in vitro. J Cell Biol. 47:1991;272.
71. Watanabe K., Tanaka Y., Morimoto I., Yahata K., Zeki K., Fujihira T., Yamashita U., Eto S. Interleukin-4 as a potent inhibitor of bone resorption. Biochem Biophys Res Commun. 172:1990;1035.
72. Riancho J.A., Zarrabeitia M.T., Gonzalez-Macias J. Interleukin-4 modulates osteoclast differentiation and inhibits the formation of resorption pits in mouse osteoclast cultures. Biochem Biophys Res Commun. 196:1993;678.
73. Nakano Y., Watanabe K., Morimoto I., Okada Y., Ura K., Sato K., Kasono K., Nakamura T., Eto S. Interleukin-4 inhibits spontaneous and parathyroid hormone-related protein-stimulated osteoclast formation in mice. J Bone Miner Res. 9:1994;1533.
74. Lewis D.B., Liggitt H.D., Effmann E.L., Motley S.T., Teitelbaum S.L., Jepsen K.J., Goldstein S.A., Bonadia J., Carpenter J., Perlmutter R.M. Osteoporosis induced in mice by overproduction of interleukin 4. Proc Natl Acad Sci U S A. 90:1993;11618.
75. Brandi M.L., Hukkanen M., Umeda T., Moradi-Bidhendi N., Bianchi S., Gross S.S., Polak J.M., MacIntyre I. Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms. Proc Natl Acad Sci U S A. 92:1995;2954.
76. Lowik C.W., Nibbering P.H., van de Ruit M., Papapoulos S.E. lnducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption. J Clin Invest. 93:1994;1465.
77. Oursler M.J., Pederson L., Fitzpatrick L., Riggs B.L., Spelsberg T. Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells. Proc Natl Acad Sci U S A. 91:1994;5227.
78. Oursler M.J., Osdoby P., Pyfferoen J., Riggs B.L., Spelsberg T.C. Avian osteoclasts as estrogen target cells. Proc Natl Acad Sci U S A. 88:1991;6613.
79. Horwood N.J., Udagawa N., Elliott J., Grail D., Okamura H., Kurimoto M., Dunn A.R., Martin T., Gillespie M.T. Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor. J Clin Invest. 101:1998;595.
80. Hakeda Y., Kobayashi Y., Yamaguchi K., Yasuda H., Tsuda E., Higashio K., Miyata T., Kumegawa M. Osteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts. Biochem Biophys Res Commun. 251:1998;796.
81. 3 receptor. J Bone Miner Res. 12:1997;S330.
82. Abe J., Takita Y., Nakano T., Miyaura C., Suda T., Nishii Y. A synthetic analogue of vitamin D3, 22-oxa-1 alpha, 25-dihydroxyvitamin D3, is a potent modulator of in vivo immunoregulating activity without inducing hypercalcemia in mice. Endocrinology. 124:1989;2645.
83. Feyen J.H., Elford P., Di Padova F.E., Trechsel U. Interleukin-6 is produced by bone and modulated by parathyroid hormone. J Bone Miner Res. 4:1989;633.
84. Uy H.L., Guise T.A., De La Mata J., Taylor S.D., Story B.M., Dallas M.R., Boyce B.F., Mundy G.R., Roodman G.D. Effects of PTHrP and PTH on osteoclasts and osteoclast precursors in vivo. Endocrinology. 36:1995;3207.
85. Rodan G.A., Martin T.J. Role of osteoblasts in hormonal control of bone resorption. a hypothesis Calcif Tissue lnt. 33:1981;349.
86. McSheehy P.M.J., Chambers T.J. Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology. 118:1986;824.
87. Lee S.K., Goldring S.R., Lorenzo J.A. Expression of the calcitonin receptor in bone marrow cell cultures and in bone. a specific marker of the differentiated osteoclast that is regulated by calcitonin Endocrinology. 136:1995;4572.
88. Takahashi S., Goldring S., Katz M., Hilsenbeck S., Williams R., Roodman G.D. Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation. J Clin Invest. 95:1995;167.
89. Gorn A.H., Rudolph S.M., Flannery M.R., Morton C.C., Weremowicz S., Wang T.Z., Krane S.M., Goldring S.R. Expression of two human skeletal calcitonin receptor isoforms cloned from a giant cell tumor of bone. The first intracellular domain modulates ligand binding and signal transduction. J Clin Invest. 95:1995;2680.
90. Wada S., Udagawa N., Akatsu T., Nagata N., Martin T.J., Findlay D.M. Regulation by calcitonin and glucocorticoids of calcitonin receptor gene expression in mouse osteoclasts. Endocrinology. 138:1997;521.
91. 2 inhibits formation of osteoclast-like cells in long-term human marrow cultures but is not a mediator of the inhibitory effects of transforming growth factor-β J Bone Miner Res. 5:1990;677.
92. Quinn J.M.W., Sabokbar A., Denne M., de Vernejoul M.C., McGee J.O.D., Athanasou N.A. Inhibitory and stimulatory effects of prostaglandins on osteoclast differentiation. Calcif Tissue Int. 60:1997;63.
93. Gallwitz W.E., Mundy G.R., Lee C.H., Qiao M., Roodman G.D., Raftery M., Gaskell S.J., Bonewald L.F. 5-Lipoxygenase metabolites of arachidonic acid stimulate isolated osteoclasts to resorb calcified matrices. J Biol Chem. 268:1993;10087.
94. Oursler M.J. Osteoclast synthesis, secretion and activation of latent transforming growth factor beta. J Bone Miner Res. 9:1994;443.
95. Takahashi S., Reddy S.V., Chirgwin J.M., Devlin R., Haipek C., Anderson J., Roodman G.D. Cloning and identification of Annexin II as an autocrine/paracrine factor that increases osteoclast formation and bone resorption. J Biol Chem. 269:1994;28696.
96. Menaa C., Devlin R.D., Reddy S.V., Gazitt Y., Choi S.J., Roodman G.D. Annexin II increases osteoclast formation by stimulating the proliferation of osteoclast precursors in human marrow cultures. J Clin Invest. in press:1999.
97. Nesbitt S.A., Horton M.A. Osteoclast annexins bind collagen and play a role in bone resorption. J Bone Miner Res. 10(suppl. 1):1995;S279.
98. Reddy S.V., Devlin R.D., Roodman G.D. Cloning and characterization of a novel autocrine osteoclast stimulating factor (OSF). J Bone Miner Res. 10(suppl. 1):1995;S325.
99. Bartkiewicz M., Hernando N., Reddy S.V., Roodman G.D., Baron R. Characterization of the osteoclast vacuolar H(+)-ATPase B-subunit. Gene. 160:1995;157.
100. Blair H.C., Teitelbaum S.L., Ghiselli R., Gluck S. Osteoclastic bone resorption by a polarized vacuolar proton pump. Science. 245:1989;855.
101. Choi S.J., Devlin R.D., Reddy S.V., Boyce B., Roodman G.D. Cloning and characterization of a novel inhibitor of osteoclast formation and bone resorption. J Bone Miner Res. 102:1998;1360.
102. Choi S.J., Devlin R.D., Reddy S.V., Roodman G.D. Cloning and identification of a novel inhibitor of osteoclast formation and bone resorption derived from an osteoclast library. J Bone Miner Res. 12:1997;S157.
103. Grigoriadis A.E., Wang Z.Q., Cecchini M.G., Hofstetter W., Felix R., Fleisch H.A., Wagner E.F. c-Fos. a key regulator of osteoclast-macrophage lineage determination and bone remodeling Science. 266:1994;443.
104. Wagner E.F., Owens J., Chambers T.J., Schreiber M., Matsuo K. Fos proteins in bone cell differentiation and development. Bone. 22:1998;35S.
105. Owens J.M., Matsuo K., Touko M., Wagner E.F., Chambers T.J. Fra-l stimulates osteoclastic differentiation and function in bipotential osteoclast-macrophage precursors. J Bone Miner Res. 12:1997;S108.
106. Franzoso G., Carlson L., Xing L., Poljak L., Shores E.W., Brown K.D., Leonardi A., Tran T., Boyce B.F., Siebenlist U. Targeted disruption of the p50 and p52 subunits of NF-κB transcription factor leads to failure of osteoclast formation and osteopetrosis. J Bone Miner Res. 12:1997;S136.
107. Soriano P., Montgomery C., Geske R., Bradley A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell. 64:1991;693.
108. Boyce B.F., Yoneda T., Lowe C., Soriano P., Mundy G.R. Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J Clin Invest. 90:1992;1622.
109. Lowe C., Yoneda T., Boyce B.F., Chen H., Mundy G.R., Soriano P. Osteopetrosis in src-deficient mice is due to an autonomous defect of osteoclasts. Proc Natl Acad Sci U S A. 90:1993;4485.
110. Schwartzberg P.L., Xing L., Hoffmann O., Lowell C.A., Garrett L., Boyce B.F., Varmus H.E. Rescue of osteoclast function by transgenic expression of kinase-deficient src in src-1-mutant mice. Genes Dev. 11:1997;2835.
111. Abu-Amer Y., Ross F.P., Schlesinger P., Tondravi M.M., Teitelbaum S.L. Substrate recognition by osteoclast precursors induces c-src/microtubule association. J Cell Biol. 137:1997;247.
112. Tanaka S., Amling M., Neff L., Peyman A., Uhlmann E., Levy J.B., Baron R. C-cbl is downstream of -src in a signalling pathway necessary for bone resorption. Nature. 383:1996;528.
113. Anderson R.E., Woodbury D.M., Jee W.S.S. Humoral and ionic regulation of osteoclast acidity. Calcif Tissue Int. 39:1986;252.
114. Fallon M.D. Alterations in the pH of osteoclast resorbing fluid reflects changes in bone degradative activity. Calcif Tissue Int. 36:1984;458.
115. Anderson R.E., Schraer H., Gay C.V. Ultrastructural immunocytochemical localization of carbonic anhydrase in normal and calcitonin treated chick osteoclasts. Anat Record. 204:1982;9.
116. Sly W.S., Whyte M.P., Sundaram V., Tashian R.E., Hewett-Emmett D., Guibaud P., Vainsel M., Baluarte H.J., Gruskin A., Al-Mosawi M., Sakati N., Ohlsson A. Carbonic anhydrase II deficiency in 12 families with the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. N Engl J Med. 313:1985;139.
117. Minkin C., Jennings J.M. Carbonic anhydrase and bone remodeling. sulfonamide inhibition of bone resorption in organ culture Science. 176:1972;1031.
118. Hughes D.E., Dai A., Tiffee J.C., Li H.H., Mundy G.R., Boyce B.F. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nature Med. 2:1996;1132.
119. Bursch W., Oberhammer F., Jirtle R.L., Askari M., Sedivy R., Grasl-Kraupp B., Purchio A.F., Schulte-Hermann R. Transforming growth factor β1 as a signal for induction of cell death by apoptosis. Br J Cancer. 67:1992;531.
120. Hughes D.E., Wright K.E., Uy H.L., Sasaki A., Yoneda T., Roodman G.D., Mundy G.R., Boyce B.F. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res. 10:1995;1478.